1. Japan Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Koken Ltd.

Koken Ltd.

TTSE:7963
1,723.00
JPY
-10.00
(-0.58%)
8.29BMarket Cap
Nov 06Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,481.49
1,482.91
1,534.33
1,579.37
1,686.78
1,660.19
1,718.54
2,028.02
2,038.26
2,136.43
2,142.59
2,176.92
2,408.46
- -
Basic EPS, GAAP
45.45
29.22
46.84
77.23
98.19
71.55
74.21
167.34
172.27
167.85
141.89
146.05
179.82
- -
Free Cash Flow per Basic Share
70.24
12.19
-112.17
105.9
-49.43
-396.47
300.15
141.75
83.36
91.01
179.5
90.09
-47.16
- -
Dividend per Share
25.11
24.95
24.92
25.2
25.15
30.08
25.26
25.04
45.24
35.63
45.63
35.32
36.04
- -
Book Value per Share
1,719.1
1,731.71
1,751.57
1,795.48
1,879.87
1,911.51
1,956.95
2,090.67
2,220.01
2,392.01
2,499.09
2,635.81
2,805.84
2,845.17
Tangible Book Value per Share
1,703.38
1,712.79
1,734.44
1,781.34
1,867.81
1,899.71
1,948.03
2,079.81
2,208.84
2,380.6
2,489.26
2,624.43
2,792.79
2,831.99
Basic Weighted Avg Shares
5
5
5
5
5
5
5
5
5
5
5
5
5
5
Sales/Revenue/Turnover
7,476
7,501
7,786
7,937
8,460
8,327
8,605
10,152
10,203
10,604
10,587
10,762
11,857
- -
Operating Margin (%)
9.01
4.94
6.76
7.99
8.58
5.61
6.6
11.16
9.27
11.17
9.52
9.38
10.72
- -
Depreciation Expense
561
505
469
436
425
461
588
596
666
594
490
441
417
- -
Net Income, GAAP
229
148
238
388
492
359
372
838
862
833
701
722
885
- -
Effective Tax Rate (%)
43.84
52.67
47.1
30.04
25.63
24.78
27.94
20.17
26.71
28.18
28.38
28
27.48
- -
Profit Margin (%)
3.07
1.97
3.05
4.89
5.82
4.31
4.32
8.25
8.45
7.86
6.62
6.71
7.47
- -
Working Capital
2,419
3,078
3,116
3,378
3,373
2,724
1,861
2,535
3,881
4,839
5,456
5,890
6,325
6,658
LT Debt
2,217
2,594
3,224
3,168
3,489
4,844
3,240
3,366
3,493
3,435
3,178
2,697
2,432
2,708
Total Equity
8,679
8,775
8,891
9,004
9,428
9,587
9,796
10,466
11,113
11,819
12,352
13,036
13,797
13,767
Return on Invested Capital (%)
1.82
1.23
1.91
2.97
3.54
2.14
2.44
5.48
4.07
4.78
3.93
3.94
4.82
- -
Return on Capital (%)
1.85
1.24
1.84
2.85
3.45
2.4
2.44
5.35
5.3
4.91
4.04
4.13
4.91
- -
Return on Common Equity (%)
2.65
1.69
2.69
4.34
5.34
3.77
3.83
8.27
7.99
7.27
5.8
5.69
6.6
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
ST Debt
2,234
- -
2,759
LT Borrowings
3,378
- -
2,700
LT Finance Leases
- -
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
5
5
5
Market Capitalization
8,156
9,290
8,289

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Mar'26
Jun'26
Total Current Assets
9,341
- -
10,723
Cash, Cash Equivalents & STI
2,697
- -
2,840
Accounts Receivable, Net
1,935
- -
1,548
Inventories
2,574
- -
3,567
Total Current Liabilities
3,352
- -
4,065
Payables & Accruals
- -
- -
- -
ST Debt
2,234
- -
2,759
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.51%
5.68%
5.84%
Free Cash Flow
-0.48%
-27.7%
-152.13%
Net Income, GAAP
20.13%
1.86%
22.61%
Sales/Revenue/Turnover
4.44%
3.22%
10.17%
Total Cash Common Dividend
6.76%
13.07%
1.61%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,427
2,367
- -
- -
10,762
2025
- -
- -
- -
- -
11,857
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
31.68
16.61
- -
- -
146.05
2025
- -
- -
- -
- -
179.82
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
35.32
2025
- -
- -
- -
- -
36.04
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Masakazu Sakai
Full Time Employees
312
Sector
Health technology
Industry
Medical specialties
Address
7, Yonbancho Tokyo TY Japan 601-8105
IPO Date
Dec 2, 1986
Website
koken-ltd.co.jp
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Koken Ltd. (7963.T) manufactures and sells occupational personal protective equipment and environmental quality improvement systems in Japan. The company operates through Mask-Related Business, Environmental-Related Businesses, and Other Businesses segments; its core products include respirators for industrial use such as particulate respirators, powered air-purifying respirators, supplied air respirators, chemical cartridge respirators, and gas masks; respirators and masks for medical facilities and general consumers; clean air solutions comprising the KOACH super clean zone creator, KOKENLAMINAR push-pull ventilation system, and LAMIKOACH air ventilation system; health solutions featuring the IMADEZE copper-based lactate antibacterial agent and functional water production systems including electrolyzed water generators, endoscope washers/disinfectors such as Kagami-Naishi II G, blood stain washer kits, and portable showers; as well as equipment for accident and disaster countermeasures, protective clothes, ear plugs, and face shields. Founded in 1943 and headquartered in Chiyoda-ku, Tokyo, Koken Ltd. maintains manufacturing facilities across Japan including Techno-Yards in Saitama, Gunma, and Kanagawa prefectures, with a consolidated workforce of 321 employees and an overseas subsidiary, SIAM KOKEN LTD., in Thailand. Recent developments include the opening of the KOACH Kumamoto showroom in September 2023 to support sales growth in the Kyushu semiconductor hub; initiation of overseas expansion with KOACH system deployment at Stanford University's semiconductor laboratory in the United States as of fiscal year 2024 forecasts; projected 65.3% year-on-year revenue increase to 1.6 billion yen in the environmental-related business driven by semiconductor market recovery and strengthened marketing; and sustained expansion of the health business segment with 15.8% sales growth to 400 million yen anticipated from endoscope washer/disinfectors.